Frick et al. (9) and Nagakita et al. (31) reported that MYD88 mutations exhibited less involvement in GI-DLBCL than in nodal DLBCL and other extranodal DLBCLs. Here, MYD88 is linked to diffuse large B-cell lymphoma.